The Amygo

A World Without Alzheimer's is Within Reach

About Us

Alzheimer's Disease (AD) is a progressive neurological disease that strips away people's memories, causing devastating effects to individuals and their families. Studies show that AD is caused by the buildup of amyloid plaque. 750,000 Canadians currently suffer from AD, where it is the 8th leading cause of death. AD is a big problem that needs a big solution, which is where Amygo Biotechnologies comes in with our flagship product, The Amygo.

Our Values

Our product and company have the purpose of extending the quality (and hopefully length) of people's lives, by helping to prevent and heal AD. As we have personal experience as family members and caretakers of people with AD, we are committed to the health and well being of our customers, and to giving them the highest caliber of device possible.

Our Founders

Tiffany Kurland

CEO, Founder

Tiffany Kurland has been researching AD since she was 8 years old when her grandfather passed away from dementia. She has had 6 more family members pass away from dementia since then. Tiffany studied molecular biology and biochemistry in the hopes of finding a cure to this disease, and so far, this is the best she can find. She first invented this device at 12 years old while brushing her teeth and thinking about how the vibrations of the electric toothbrush helped to get rid of plaque in the mouth, why can't we do that for plaque in the brain. Through much extensive research (12 more years of it), she has discovered her hypothesis was correct.

Max Zou

CSO, Co-Founder

Max is an electrical engineer, with a background in electronics in industrial appliances and robotics. Max has enjoyed robotics and engineering as a hobby since early elementary school, and eventually worked at Tesla motors as an electrical design engineer. While seeking an impactful project to work on in university, he joined Tiffany on the Amygo project.